National Medical Health Card Systems Inc
National Medical Health Card Systems — Conference Presentation (June 2006)
26 slides from National Medical Health Card Systems's conference presentation, Jun 22, 2006
Slide 1: National Medical Health Card Systems, Inc.
National Medical National Medical Health Card Systems, Inc. Health Card Systems, Inc. (NASDAQ: NMHC) (NASDAQ: NMHC) Exhibit 99.1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Safe Harbor Statement This slide presentation contains forward-looking projections which involve known and unknown risks and uncertainties or other factors that may cause actual results, performance or achievements to be materially different from any future results, performance
Slide 3: Investment Highlights
Investment Highlights Investment Highlights • Middle-market leader, differentiated by in-house capabilities, flexibility and superior ability to manage pharmaceutical costs • Opportunity to cross sell high margin services to existing clients • Investments in infrastructure set stage for margin expan
Slide 4: What is a PBM?
What is a PBM? What is a PBM? PBMs provide custom-tailored prescription benefit plans and formularies that help reduce their clients’ drug costs Patient Payer Pharmaceutical company Pharmacy Physician
Slide 5: Why use a PBM?
Why use a PBM? Why use a PBM? • Purchasing power • Benefit design consulting • Substitution of preferred/generic brands • Specialty pharmacy services • Home delivery services
Slide 6: Prescription Growth Trends
Prescription Growth Trends Prescription Growth Trends 9.0 6.5 5.6 4.5 2.6 2.3 3.3 MAT June % Change in Total Prescriptions Dispensed Source: IMS Health: National Prescription Audit (NPA) PIUS, Monthly Rx Audit, July 2005
Slide 7: Industry Drivers
Industry Drivers Industry Drivers Increased adoption of mandatory mail programs Home delivery accounts for 17% of all prescription sales Home Delivery Increased prescription use due to Medicare Part D By 2010, seniors aged 55-64 will increase by nearly 50% Drug spending increasing 10-12% annually PB
Slide 8: Middle-Market Opportunity
Big 3 PBMs Middle-Market Opportunity Middle-Market Opportunity • Most Americans employed with middle market employers • Historically underserved by larger PBMs – “Shell game” perception • Loyal purchasers/higher margin • High degree of fragmentation of smaller PBMs Middle Market Multiple small/regio
Slide 9: What Do Middle Market Clients Want?
What Do Middle Market Clients Want? What Do Middle Market Clients Want? • One stop shopping • Transparent business model • Patient/clinical management • Specialty strategies for high cost injectables • Low price Flexibility, Flexibility, Flexibility
Slide 10: NMHC Total Healthcare Solutions
4% NMHC 47 Total Healthcare Solutions
Slide 11: PBM Services
PBM Services PBM Services • Claims Management • Pharmacy Network • Benefit Design Consultation • Drug Review & Analysis • Formulary Design and Disease Information Services • Data Access, Reporting & Information Analysis • Physician Profiling Preferred Partnership Program offers complete pass through
Slide 12: Home Delivery
Home Delivery Home Delivery • Mail service pharmacy for chronic therapy medications • Launched July 2003 • 30,000 square foot facility • Currently at 20% of capacity Home Delivery
Slide 13: Specialty Pharmacy
Specialty Pharmacy Specialty Pharmacy • High cost self-injected medications and compounded prescriptions that require special handling – Represents 1% of population and 15% of total drug spend – Strong biotech pipeline will lead to increased utilization • Built around case management, not product fu
Slide 14: Risk Management
Risk Management Risk Management • Level 1: Pharmacy Cost Control – Full suite of Rx management services – Measurable savings for cost-conscious plans • Level 2: Pharmacy Cost Control+ – Rx management tuned through Rx-based risk prediction – Incremental savings for progressive plans • Level 3: Pharma
Slide 15: Total Healthcare Solutions
Total Healthcare Solutions Total Healthcare Solutions Unmatched Middle-Market Capabilities
Slide 16: Customer Composition
33% 18% 24% 22% 3% Customer Composition Customer Composition 33% 18% 24% 22% 3% Managed Medicaid Third Party Administrators Taft-Hartley Other Managed Care
Slide 17: Competitive Advantage: Customer Services
Competitive Advantage: Customer Services Competitive Advantage: Customer Services 6.5 7.5 8.5 9.5 Retail Pharmacy Network Claim Processing Management Reports Delivering Promised Services Overall Service and Performance Eligibility Management Drug Utilization Management Customer and Member Service De
Slide 18: Competitive Advantage: Medicare Part D
Competitive Advantage: Medicare Part D Competitive Advantage: Medicare Part D • Unique capabilities among middle-market PBMs • MA-PD Medicare plan sponsor support – Complete back office operational support – Clinical, systems, CMS communications and policy support • Employer and union support – Medi
Slide 19: Competitive Advantages
Competitive Advantages Competitive Advantages • Proven track record and industry leadership in controlling drug cost inflation • Greater flexibility and highest rated in customer satisfaction • Fair and transparent reporting • Comprehensive in-house offerings and risk management solutions • Medicare
Slide 20: Growth Initiatives
Growth Initiatives Growth Initiatives • New client acquisition – Expanding senior sales team • New senior VP sales – Attack 3 primary verticals: • Third-Party Administrator & Employer • Taft-Hartley (Union) • Managed Care – Competing for larger accounts with Integrated Services Suite as key differen
Slide 21: Acquisition Strategy
Big 3 NMHC Acquisition Strategy Acquisition Strategy • Acquire Small/Regional PBMs – Easy entry but significant challenges to scale – Accelerating consolidation with regional PBMs unable to meet Part D requirements • Acquire Specialty Pharmacy Co’s – Increase purchasing power – Expand geographic rea
Slide 22: NMHC Performance
Five-year Revenue CAGR of 37% Five-year EBITDA CAGR of 53% FY’05 Net Income Up 31% Year Over Year** Profitable Every Year Since 1996* $3.2 $3.7 $11.2 $16.4 $19.3 $27.0 $1.6 $1.2 $4.5 $6.4 $9.5 $12.4 FY00 FY01 FY02 FY03 FY04 FY05 EBITDA* Net Income Revenue $167.7 $272.1 $459.8 $573.3 $651.1 $800.1 ($
Slide 23: Balance Sheet Highlights
Cash & Cash Equivalents Total Assets Total Liabilities 03/31/06 6/30/05 $ 10,244 $ 7,272 Total Current Assets 180,374 166,798 298,678 283,931 Total Current Liabilities 192,108 191,235 199,846 198,213 Total Redeemable Preferred Equity and Common Stockholders’ Equity 98,832 85,718 ($ in thousands) Bal
Slide 24: Investment Highlights
Investment Highlights Investment Highlights • Middle-market leader, differentiated by in-house capabilities, flexibility and superior ability to manage pharmaceutical costs • Opportunity to cross sell high margin services to existing clients • Investments in infrastructure set stage for margin expan
Slide 25: EBITDA Reconciliation
EBITDA Reconciliation EBITDA Reconciliation Cash Flow From Operations $5,803 $12,091 $12,415 $15,868 $24,060 $10,322 Provision for Income Taxes 1,247 2,900 4,602 5,524 8,031 Interest (Income) Expense, Net (922) (877) Net Change in Assets and Liabilties (884) (6,644) (4,404) (4,613) (7,823) 11,988 No
Slide 26: EBITDA Reconciliation
EBITDA Reconciliation EBITDA Reconciliation Three of the Company’s financial covenants under its revolving credit facility (“Facility”) are based upon the EBITDA (earnings before interest, taxes, depreciation and amortization) generated by the Company over specified periods of time. These covenants,
National Medical Health Card Systems — Conference Presentation (June 2006) on 6ix